Breaking News Instant updates and real-time market news.

TEVA

Teva

$8.24

-0.37 (-4.30%)

07:08
06/17/19
06/17
07:08
06/17/19
07:08

Teva price target lowered to $13 from $23 at Citi

Citi analyst Liav Abraham cut her price target for Teva Pharmaceutical to $13 from $23 after exploring some of the key questions and issues associated with the company's opioid litigation. The analyst, who keeps a Buy rating on the shares, acknowledges that the "highly complex nature of the litigation implies that certain questions remain unanswered."

TEVA Teva
$8.24

-0.37 (-4.30%)

06/03/19
06/03/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Black Knight (BKI) upgraded to Buy from Neutral at Goldman Sachs with analyst James Schneider saying the company's "strong" pipeline of new bank client wins in both mortgage servicing and origination software should drive accelerating revenue growth over 2019 and into 2020 relative to recent quarters. 2. AMC Networks (AMCX) upgraded to In-Line from Underperform at Imperial Capital with analyst David Miller citing valuation. 3. BT Group (BT) upgraded to Outperform from Neutral at Credit Suisse with analyst Paul Sidney saying he has a "much increased" level of confidence in the company's ability to return to sustainable EBITDA growth in fiscal 2021. 4. Brinker (EAT) upgraded to Neutral from Sell at UBS with analyst Dennis Geiger saying that with the stock falling below that level, valuation now appears to reflect the challenges of his April initiation. 5. Teva (TEVA) upgraded to Outperform from Perform at Oppenheimer with analyst Esther Rajavelu saying the shares, trading at its 19-year low, offer a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/11/19
LEHM
06/11/19
INITIATION
Target $8
LEHM
Underweight
Teva initiated with an Underweight at Barclays
Barclays analyst Balaji Prasad started Teva Pharmaceutical Industries with an Underweight rating and $8 price target. The analyst launched coverage of 20 U.S. Specialty Pharmaceuticals with a Neutral industry view. He placed importance on cash flows and companies' ability to manage leverage and improve balance sheets.
06/12/19
CANT
06/12/19
NO CHANGE
Target $9
CANT
Neutral
Teva price target lowered to $9 from $16 at Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen lowered her price target for Teva to $9 from $16, driven by multiple contraction, given increasing headwinds from macro factors. The analyst reiterates a Neutral rating on the shares.
06/12/19
WELS
06/12/19
NO CHANGE
WELS
Market Perform
Wells sees Teva shares rebounding from selloff on settlement denial
This morning, Oklahoma Judge Thad Balkman reportedly declined to approve the state's $85M opioid settlement with Teva Pharmaceuticals, Wells Fargo analyst Davis Maris tells investors in a research note. However, the analyst believes the development sounds like "more of an administrative burden rather than a threat to the actual settlement." As such, the 7% pullback in Teva shares "seems overdone," says Maris, who adds that the selloff shows how sensitive investors are to litigation risk. He expects Teva shares to rebound off of the morning's lows. Maris has a Market Perform rating on Teva.

TODAY'S FREE FLY STORIES

LK

Luckin Coffee

$20.03

0.07 (0.35%)

07:42
07/22/19
07/22
07:42
07/22/19
07:42
Hot Stocks
Luckin Coffee, Americana Group to establish JV for retail coffee business »

Luckin Coffee and Kuwait…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$258.12

4.3 (1.69%)

07:41
07/22/19
07/22
07:41
07/22/19
07:41
Recommendations
Tesla analyst commentary  »

Profitability, demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

LII

Lennox

$279.06

-4.87 (-1.72%)

07:40
07/22/19
07/22
07:40
07/22/19
07:40
Hot Stocks
Lennox down 5% after Q2 results miss estimates, FY19 outlook lowered »

In pre-market trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 13

    Nov

AVP

Avon Products

$3.99

0.035 (0.89%)

07:39
07/22/19
07/22
07:39
07/22/19
07:39
Hot Stocks
Avon Products appoints Luis Vazquez as leader of its global sales team »

Avon Products announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

CIR

Circor

$38.66

0.63 (1.66%)

, CR

Crane

$85.51

2.04 (2.44%)

07:38
07/22/19
07/22
07:38
07/22/19
07:38
Hot Stocks
Circor comments on expiration of Crane tender offer »

Circor (CIR) issued the…

CIR

Circor

$38.66

0.63 (1.66%)

CR

Crane

$85.51

2.04 (2.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 01

    Aug

  • 09

    Sep

  • 09

    Sep

TSLA

Tesla

$258.12

4.3 (1.69%)

07:38
07/22/19
07/22
07:38
07/22/19
07:38
Downgrade
Tesla rating change  »

Tesla downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

LII

Lennox

$279.06

-4.87 (-1.72%)

07:38
07/22/19
07/22
07:38
07/22/19
07:38
Hot Stocks
Lennox CEO says 'significantly cooler temperatures' impacted HVAC market in Q2 »

"Significantly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 13

    Nov

RF

Regions Financial

$15.12

0.36 (2.44%)

07:37
07/22/19
07/22
07:37
07/22/19
07:37
Upgrade
Regions Financial rating change  »

Regions Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

EIDX

Eidos Therapeutics

$34.87

-1.4 (-3.86%)

07:37
07/22/19
07/22
07:37
07/22/19
07:37
Recommendations
Eidos Therapeutics analyst commentary  »

Eidos Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SALT

Scorpio Bulkers

$6.25

0.165 (2.71%)

07:37
07/22/19
07/22
07:37
07/22/19
07:37
Earnings
Scorpio Bulkers reports Q2 adjusted EPS 58c, consensus (21c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

OFG

OFG Bancorp

$23.30

-0.02 (-0.09%)

07:36
07/22/19
07/22
07:36
07/22/19
07:36
Earnings
OFG Bancorp reports Q2 EPS 43c, consensus 43c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

ZVO

Zovio

$4.02

0.02 (0.50%)

, DAL

Delta Air Lines

$60.91

-1.75 (-2.79%)

07:35
07/22/19
07/22
07:35
07/22/19
07:35
Hot Stocks
Zovio teams up with Delta Air Lines for tuition assistance program »

Zovio has teamed up with…

ZVO

Zovio

$4.02

0.02 (0.50%)

DAL

Delta Air Lines

$60.91

-1.75 (-2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$279.06

-4.87 (-1.72%)

07:35
07/22/19
07/22
07:35
07/22/19
07:35
Hot Stocks
Lennox cuts FY19 free cash flow view to approximately $390M from $420M »

Reiterating guidance for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 13

    Nov

CHCO

City Holding

$73.71

-0.21 (-0.28%)

07:35
07/22/19
07/22
07:35
07/22/19
07:35
Earnings
City Holding reports Q2 EPS $1.38, consensus $1.30 »

Reports Q2 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$29.41

-0.07 (-0.24%)

, MU

Micron

$45.51

0.85 (1.90%)

07:35
07/22/19
07/22
07:35
07/22/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$29.41

-0.07 (-0.24%)

MU

Micron

$45.51

0.85 (1.90%)

ITCI

Intra-Cellular

$11.84

0.06 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 06

    Aug

  • 06

    Sep

  • 27

    Sep

  • 16

    Oct

07:35
07/22/19
07/22
07:35
07/22/19
07:35
General news
Treasury Market Outlook: Treasury yields are lower »

Treasury Market Outlook:…

UNCFF

UniCredit

$0.00

(0.00%)

07:34
07/22/19
07/22
07:34
07/22/19
07:34
Periodicals
UniCredit may cut up to 10,000 jobs in effort to reduce costs, Bloomberg reports »

UniCredit is considering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VYST

Vystar Corp

$0.00

(0.00%)

07:34
07/22/19
07/22
07:34
07/22/19
07:34
Hot Stocks
Vystar Corp acquires controlling interest in Rotmans Furniture for $2.03M »

Vystar announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$258.12

4.3 (1.69%)

07:34
07/22/19
07/22
07:34
07/22/19
07:34
Downgrade
Tesla rating change at Roth Capital »

Tesla downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

LII

Lennox

$279.06

-4.87 (-1.72%)

07:33
07/22/19
07/22
07:33
07/22/19
07:33
Earnings
Lennox cuts FY19 adjusted revenue growth view to 2%-5% from 3%-7% 

FY19 consensus $3.89B.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 13

    Nov

BHVN

Biohaven Pharmaceutical

$44.16

-0.61 (-1.36%)

07:33
07/22/19
07/22
07:33
07/22/19
07:33
Hot Stocks
Biohaven enrollment for Phase 2/3 trial of troriluzole progresses on timeline »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

AAPL

Apple

$202.62

-3.02 (-1.47%)

07:32
07/22/19
07/22
07:32
07/22/19
07:32
Recommendations
Apple analyst commentary at Morgan Stanley »

Morgan Stanley says Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 03

    Aug

LII

Lennox

$279.06

-4.87 (-1.72%)

07:32
07/22/19
07/22
07:32
07/22/19
07:32
Hot Stocks
Breaking Hot Stocks news story on Lennox »

Lennox backs FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 13

    Nov

AXP

American Express

07:31
07/22/19
07/22
07:31
07/22/19
07:31
Recommendations
American Express analyst commentary  »

American Express price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

AXP

American Express

$124.82

-3.58 (-2.79%)

07:31
07/22/19
07/22
07:31
07/22/19
07:31
Recommendations
American Express analyst commentary  »

American Express price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.